Oxford BioMedica (OTCMKTS:OXBDF) Short Interest Down 25.6% in August

Key Points

• Short interest in Oxford BioMedica decreased by 25.6% in August, dropping from 320,100 shares to 238,000 shares.
• The short-interest ratio is currently at 103.5 days, indicating a low percentage of shares sold short at only 0.2%.
• Oxford BioMedica's stock price held steady at $7.35, with a significant trading volume contrast—only 1 share traded compared to its average of 581 shares.

Oxford BioMedica (OTCMKTS:OXBDF - Get Free Report) saw a large drop in short interest in August. As of August 31st, there was short interest totaling 238,000 shares, a drop of 25.6% from the August 15th total of 320,100 shares. Based on an average daily volume of 2,300 shares, the short-interest ratio is currently 103.5 days. Approximately 0.2% of the company's stock are short sold. Approximately 0.2% of the company's stock are short sold. Based on an average daily volume of 2,300 shares, the short-interest ratio is currently 103.5 days.

Oxford BioMedica Stock Down 0.4%

Shares of OXBDF traded down $0.03 during midday trading on Friday, reaching $7.77. 800 shares of the stock were exchanged, compared to its average volume of 1,006. Oxford BioMedica has a 12-month low of $3.15 and a 12-month high of $7.80. The firm has a 50 day simple moving average of $6.49 and a 200-day simple moving average of $4.87.

About Oxford BioMedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.